Hodis HN - Search Results

1

Blankenhorn DH, Hodis HN. Blankenhorn DH, et al. Among authors: hodis hn. West J Med. 1993 Aug;159(2):172-9. West J Med. 1993. PMID: 8212682 Free PMC article. Review.

2

Relationship of arterial wall uptake of radiolabeled liposomes to the presence of monocyte/macrophage cells in the hypertensive and atherosclerotic arterial wall.

Hodis HN, Amartey JK, Crawford DW, Wickham E, Sharma RC, Blankenhorn DH. Hodis HN, et al. Atherosclerosis. 1991 Apr;87(2-3):109-17. doi: 10.1016/0021-9150(91)90013-s. Atherosclerosis. 1991. PMID: 1854358

3

Treating serum lipid abnormalities in high-priority patients.

Blankenhorn DH, Hodis HN. Blankenhorn DH, et al. Among authors: hodis hn. Postgrad Med. 1991 Jan;89(1):81-2, 87-90, 93-6. doi: 10.1080/00325481.1991.11700787. Postgrad Med. 1991. PMID: 1985320 Review.

4

In vivo hypertensive arterial wall uptake of radiolabeled liposomes.

Hodis HN, Amartey JK, Crawford DW, Wickham E, Blankenhorn DH. Hodis HN, et al. Hypertension. 1990 Jun;15(6 Pt 1):600-5. doi: 10.1161/01.hyp.15.6.600. Hypertension. 1990. PMID: 2347622

5

Compensatory vascular changes of remote coronary segments in response to lesion progression as observed by sequential angiography from a controlled clinical trial.

Shircore AM, Mack WJ, Selzer RH, Lee PL, Azen SP, Alaupovic P, Hodis HN. Shircore AM, et al. Among authors: hodis hn. Circulation. 1995 Nov 1;92(9):2411-8. doi: 10.1161/01.cir.92.9.2411. Circulation. 1995. PMID: 7586339 Clinical Trial.

6

Triglyceride-rich lipoproteins and the progression of coronary artery disease.

Hodis HN, Mack WJ. Hodis HN, et al. Curr Opin Lipidol. 1995 Aug;6(4):209-14. doi: 10.1097/00041433-199508000-00004. Curr Opin Lipidol. 1995. PMID: 7670749 Review.

7

Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis.

Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP. Hodis HN, et al. JAMA. 1995 Jun 21;273(23):1849-54. JAMA. 1995. PMID: 7776501 Clinical Trial.

8

Prevention of coronary atherosclerosis.

Hodis HN, Cashin-Hemphill L, Mack WJ. Hodis HN, et al. Heart Dis Stroke. 1994 Jul-Aug;3(4):182-7. Heart Dis Stroke. 1994. PMID: 7921660 Review. No abstract available.

9

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

Alaupovic P, Hodis HN, Knight-Gibson C, Mack WJ, LaBree L, Cashin-Hemphill L, Corder CN, Kramsch DM, Blankenhorn DH. Alaupovic P, et al. Among authors: hodis hn. Arterioscler Thromb. 1994 Dec;14(12):1906-13. doi: 10.1161/01.atv.14.12.1906. Arterioscler Thromb. 1994. PMID: 7981178 Clinical Trial.

10

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.

Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH. Hodis HN, et al. Circulation. 1994 Jul;90(1):42-9. doi: 10.1161/01.cir.90.1.42. Circulation. 1994. PMID: 8026027 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page